12/11/2014 - 3:24pm

Teva Pharmaceuticals on Thursday announced the availability of levalbuterol inhalation solution, USP (concentrate), a generic equivalent to Xopenex inhalation solution concentrate. 

12/11/2014 - 3:15pm

Lupin Pharmaceuticals launched the authorized generic version of Celebrex capsules in 50-, 100-, 200- and 400-mg dosage strengths. 

12/11/2014 - 1:21pm

Mylan on Thursday announced the launch of methocarbamol injection USP, 100 mg. 

12/11/2014 - 1:14pm

Mylan on Thursday announced the launch of prednisolone sodium phosphate orally disintegrating tablets in 10-mg, 15-mg and 30-mg dosage strengths. 

 

12/11/2014 - 11:44am

The Food and Drug Administration on Wednesday approved Gardasil 9 for the prevention of certain diseases caused by nine types of human papillomavirus.

12/10/2014 - 10:51am

Teva Pharmaceutical Industries on Wednesday announced the launch of generic Celebrex (celecoxib) capsules in the United States. The company is offering the capsules in 50-,100-, 200- and 400-mg dosage strengths. 

 

12/10/2014 - 10:39am

Mylan on Wednesday launched its celecoxib capsules in 50-, 100-, 200- and 400-mg dosage strengths. The drug is one of the first available generic versions of Celebrex capsules from Pfizer.

12/05/2014 - 11:15am

Greenstone announced the introduction of cabergoline tablets to its line of pharmaceutical products.

 

12/04/2014 - 3:12pm

Camber Pharmaceuticals announced the addition of montelukast sodium tablets to its portfolio of products.